Liver stem cell-derived β-cell surrogates for treatment of type 1 diabetes
- 22 December 2005
- journal article
- review article
- Published by Elsevier
- Vol. 5 (6) , 409-413
- https://doi.org/10.1016/j.autrev.2005.10.009
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Role of Pax4 in Pdx1-VP16-mediated liver-to-endocrine pancreas transdifferentiationLaboratory Investigation, 2006
- Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1- and Pdx1-VP16 mediated by lentiviral vectorsLaboratory Investigation, 2006
- In vitro transdifferentiation of hepatoma cells into functional pancreatic cellsMechanisms of Development, 2005
- Constitutively active PDX1 induced efficient insulin production in adult murine liverBiochemical and Biophysical Research Communications, 2005
- Functional, Persistent, and Extended Liver to Pancreas TransdifferentiationJournal of Biological Chemistry, 2003
- In vitro differentiation of WB-F344 rat liver epithelial cells into the biliary lineageDifferentiation, 2002
- Transdifferentiation and metaplasia — switching cell typesCurrent Opinion in Genetics & Development, 2001
- In-vitro differentiation of pancreatic β-cellsDifferentiation, 2001
- Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequenceNature Genetics, 1997
- GAL4-VP16 is an unusually potent transcriptional activatorNature, 1988